Navigation Links
Fully dissolvable, temporary stent for opening heart artery blockages
Date:9/17/2013

er one killer of Americans. This is why we need to study in clinical trial every available therapeutic option for our heart patients to improve their overall heart health and prevent future deadly heart attacks," says Roxana Mehran, MD, Director of Interventional Cardiovascular Research and Clinical Trials at Icahn School of Medicine at Mount Sinai. "It is critical that advances in cardiac interventional technology, currently being used on other continents to help unblock arteries, be tested in clinical trial in the U.S."

The randomized ABSORB III clinical trial plans to enroll approximately 2,250 coronary artery disease patients across the country. Mount Sinai hopes to enroll 50 patients.

Recently, Absorb BVS became commercially available in Europe, India, and parts of Latin America and Asia. So far, more than 1,000 patients around the world have been treated with the device. Absorb BVS is made by the global healthcare company Abbott.


'/>"/>

Contact: Lauren Woods
lauren.woods@mountsinai.org
212-241-2836
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. How to learn successfully even under stress
2. New beautifully colored long-horned beetle from Yunnan, China
3. Chinese scientists successfully crack the genome of diploid cotton
4. Efforts to develop new drugs that hopefully will never be used
5. Scale-up of a temporary bioartificial liver support system described in BioResearch Open Access
6. Temporary storage for electrons: Natural method of producing hydrogen
7. New compound excels at killing persistent and drug-resistant tuberculosis
8. Stenting dramatically improves treatment access for dialysis patients
9. Drug-coated stents prevent leg amputation
10. Stenting blocked bowel arteries saves lives
11. Global nitrogen availability consistent for past 500 years, linked to carbon levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... the roughly 156,000 gas stations across the United ... of underground gas storage tankscorrosion that could result ... source of drinking water. In recent years, field ... corroding gas storage tank components such as sump ... of gasoline-ethanol blends and the presence of bacteria, ...
(Date:7/31/2014)... An experimental vaccine protected 100 percent of animal models ... difficile , which causes an intestinal disease that kills ... of print in Infection and Immunity . ... and non-human primates against the purified toxins produced by ... orogastric spore infection, a laboratory model that mimics the ...
(Date:7/31/2014)... step has been made to help better identify and treat ... abnormal narrowing and enlarging of medium sized arteries in the ... other organs causing damage. In a new report appearing in ... , scientists provide evidence that that FMD may not be ... show a connection to abnormalities of bones and joints, as ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2C. difficile vaccine proves safe, 100 percent effective in animal models 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... a trigger that induces B cells to produce effective and ... a molecule that binds toll-like receptors (TLR) doubles the early ... more effective, IgG form. , The findings, published online and ... of Experimental Medicine , support the emerging concept of ,bridge ...
... July 6 Aware, Inc. (Nasdaq: ... software, today announced that it has supplied its Biometric ... police agency analogous to the U.S. FBI. BioSP is ... product being used by the police agency for several ...
... a new means of determining the sex of skeletal human ... the wake of disasters, the studying of ancient remains and ... able to determine the sex of skeletal remains by visually ... coxa. "This technique is accurate, but is not without its ...
Cached Biology News:Researchers discover trigger to early, effective antibody response 2Researchers discover trigger to early, effective antibody response 3Aware's Biometric Services Platform (BioSP) Deployed By a Large European Police Agency 2Aware's Biometric Services Platform (BioSP) Deployed By a Large European Police Agency 3Aware's Biometric Services Platform (BioSP) Deployed By a Large European Police Agency 4Hips don't lie: Researchers find more accurate technique to determine sex of skeletal remains 2
(Date:8/1/2014)... , Aug. 1, 2014 One of ... rise of personalized medicine, which is the practice of ... treatments to a patient,s individual biology. Personalized diagnostics—laboratory analyses ... major role in the lab,s future. This fall, ... feature the latest science in this exciting field and ...
(Date:8/1/2014)... Research and Markets has announced the addition ... and Analysis Market 2014-2018" report to their offering. ... Single Nucleotide Polymorphism (SNP) genotyping is the screening and ... of various species. SNPs are commonly present in all ... analyze thousands of SNPs and has the potential for ...
(Date:8/1/2014)... N.J., Aug. 1, 2014 Cambrex Corporation (NYSE: ... June 30, 2014. Highlights , ... million in the same period last year. , Second ... million in the same period last year (see table at ... sales guidance increased, excluding the impact of foreign currency, to ...
(Date:7/31/2014)... Food and natural product manufacturers, ... food alternatives that offer variety, as well as, ... market has numerous players operating in the marketplace ... Technology (VFT). VFT is a science-driven functional ... all tested to produce stable, effective and repeatable ...
Breaking Biology Technology:First-Ever AACC Virtual Conference to Focus on Personalized Diagnostics 2Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Cambrex Reports Second Quarter 2014 Financial Results 2Cambrex Reports Second Quarter 2014 Financial Results 3Cambrex Reports Second Quarter 2014 Financial Results 4Cambrex Reports Second Quarter 2014 Financial Results 5Cambrex Reports Second Quarter 2014 Financial Results 6Cambrex Reports Second Quarter 2014 Financial Results 7Cambrex Reports Second Quarter 2014 Financial Results 8Cambrex Reports Second Quarter 2014 Financial Results 9Cambrex Reports Second Quarter 2014 Financial Results 10Cambrex Reports Second Quarter 2014 Financial Results 11Cambrex Reports Second Quarter 2014 Financial Results 12Cambrex Reports Second Quarter 2014 Financial Results 13Cambrex Reports Second Quarter 2014 Financial Results 14Cambrex Reports Second Quarter 2014 Financial Results 15Cambrex Reports Second Quarter 2014 Financial Results 16Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2
... Advanced Chemical Transport, one of the leading ... with Gilead Sciences Inc., North America,s third largest Bio-Med ... - including hazardous Materials disposal, vacuum truck services, spill ... from its corporate headquarters in Sunnyvale, CA. , ...
... BC, July 2 /PRNewswire-FirstCall/ - avVaa World Health ... biotechnology company, manufacturer and distributor of nationally branded ... the engagement of Koeppel Direct to manage their ... of avVaa World Health Care is excited to ...
... - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... completed in the Phase II component of a Phase ... patients with advanced cancers. The principal investigators for the ... Cancer Research, London, England, and Dr. Geoff Hall of ...
Cached Biology Technology:avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign 2Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial 2
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
... for Sequencing allow 5-minute cloning and subsequent sequencing ... vectors with primer sites located as close as ... site. This minimizes the amount of vector DNA ... sequence of your insert.vectors are available. The pCR4-TOPO ...
Carp Vitellogenin ELISA System, 96 wells. ELISARange: 5.0-225 ng/ml.Sensitivity: 5.0 ng/ml.Sample volume: 100 ul.Suitable for use with Carp plasma samples.3-h protocol.Store at 2-8 C. Category: Drug ...
Quartz-Halogen, 100 W, High Intensity...
Biology Products: